Evidence map›Paper›PMID 40820918›Full record

ArticleJournal of neurochemistry2025

Contrasting Behavioural and Biochemical Characteristics of Normal and Spontaneously α-Synuclein-Deficient Mice Treated With MPTP.

W H Powell, A Ghita, F C Pascut, K F Webb, A Newman-Tancredi, M M Iravani

Abstract read
In one paragraph

Article in Journal of neurochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

W H PowellDepartment of Clinical, Biological and Pharmaceutical Sciences, University of Hertfordshire, Hatfield, UK.
A GhitaDepartment of Clinical, Biological and Pharmaceutical Sciences, University of Hertfordshire, Hatfield, UK.
F C PascutOptics & Photonics Research Group, Faculty of Engineering, University of Nottingham, Nottingham, UK.
K F WebbOptics & Photonics Research Group, Faculty of Engineering, University of Nottingham, Nottingham, UK.
A Newman-TancrediNeurolixis SAS, Castres, France.
M M IravaniDepartment of Clinical, Biological and Pharmaceutical Sciences, University of Hertfordshire, Hatfield, UK.ORCID https://orcid.org/0000-0002-4905-9682

Funding

European Union Regional Development FundHertfordshire Knowledge Exchange Partnership (HKEP)
6 · The paper itself

Abstract

α-Synuclein is the primary toxic constituent of Lewy bodies, but its exact function under homeostatic conditions remains elusive. To better understand the role of α-synuclein, we compared two C57BL sub-strains: the normal α-synuclein-expressing J6 and the α-synuclein-deficient J6-OlaHSD, for behavioural, dopaminergic and glial integrity in substantia nigra (SN) and caudate putamen (CPu) before and after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment. After MPTP treatment, J6 mice showed significant weight loss (-7% by Day 10), whereas OlaHSD mice maintained stable body weight. At baseline, J6 mice exhibited 33% higher locomotor activity but 38% more thigmotaxis, and 33% less endurance on the Rotarod test than OlaHSD mice. Loss of tyrosine hydroxylase-positive neurons was similar in OlaHSD (-40%) and J6 mice (-34%). J6 mice had double the SN GFAP-ir cells of J6-OlaHSD, a difference that was unchanged by MPTP treatment. In the CPu, MPTP increased GFAP-ir cells in both strains, but Iba1-ir cells significantly increased only in MPTP-treated OlaHSD mice, compared to J6 strain. We further compared the biochemical signatures using Raman micro-spectroscopy. The Raman spectra of the freshly cut SN sections showed a greater shift in the α-helix to β-sheet protein conformation ratio in MPTP-induced J6 mice, likely due to the absence of the Snca1 gene in OlaHSD mice. These findings suggest that the absence of α-synuclein plays a subtle role in the behavioural and neurochemical differences but has no significant effect on dopaminergic neurotransmission. It is therefore concluded that the presence of α-synuclein is important for non-dopaminergic behaviours such as anxiety-like behaviours and regulation of body weight. Under toxic challenge, gliosis in the SN and CPu may be regulated by α-synuclein. This study also emphasises the utility of Raman spectroscopy as a potential tool for identifying subtle protein conformation differences in mice with and without Snca1.

Indexed as

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridinealpha-SynucleinBehavior, AnimalMPTP PoisoningAnimalsMaleMiceMice, Inbred C57BLMotor ActivitySubstantia NigraTyrosine 3-Monooxygenase1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridinealpha-SynucleinTyrosine 3-Monooxygenase1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)astrocytesdopamine neuronGFAPIBA‐1microgliaParkinson's disease modelRaman spectroscopyα‐synucleinα‐synuclein deficiency

Identifiers

PMID40820918
PMCPMC12359103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.